Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DNA Script has commercialized the world’s first benchtop enzymatic DNA printer—the SYNTAX System—enabling rapid, on-demand production of custom oligonucleotides using proprietary Enzymatic DNA Synthesis technology. The company’s technology accelerates research in genomics and synthetic biology and has been leveraged in high-profile collaborations for vaccine development and molecular diagnostics. Recent advances include breaking barriers in sequence length/complexity and supporting rapid mRNA vaccine prototyping.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DNA Script.